Profil
Eric Lachenmeier is Vice President of Corporate Development for Complete Genomics, Inc. Previously, he was Vice President of Technology Development for Applied Biosystems (NASDAQ: ABI) and Incyte Genomics (NASDAQ: INCY).
Mr. Lachenmeier has 20 years of experience in technology and biotechnology with both venture-funded startups and public companies.
He received a BS degree in Mechanical Engineering from the Massachusetts Institute of Technology (MIT) and an MBA from the Wharton School of Business.
Anciens postes connus de Eric Lachenmeier
| Sociétés | Poste | Fin |
|---|---|---|
Applied Biosystems, Inc.
Applied Biosystems, Inc. Medical SpecialtiesHealth Technology Manufactures genomics and proteomics related research instruments | Corporate Officer/Principal | - |
| INCYTE CORPORATION | Corporate Officer/Principal | - |
| COMPLETE GENOMICS, INC. | Corporate Officer/Principal | - |
Formation de Eric Lachenmeier
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Entreprise privées | 5 |
|---|---|
Incyte Corp.
Incyte Corp. Pharmaceuticals: MajorHealth Technology Engages in discovery, development and commercialization of proprietary therapeutics | Health Technology |
Complete Genomics, Inc.
Complete Genomics, Inc. BiotechnologyHealth Technology Develops and markets DNA sequencing technology | Health Technology |
University of Pennsylvania
University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Massachusetts Institute of Technology
Massachusetts Institute of Technology Finance/Rental/LeasingFinance Functions as a College/University | Finance |
Applied Biosystems, Inc.
Applied Biosystems, Inc. Medical SpecialtiesHealth Technology Manufactures genomics and proteomics related research instruments | Health Technology |
















